Tag: BAVENCIO
First dose administered in Efti, BAVENCIO trial for metastatic urothelial cancer
Immutep Limited, a pioneering clinical-stage biotechnology company specializing in LAG-3 immunotherapies, announced the enrollment and safe dosing of the first patient in the INSIGHT-005 Phase I trial in the fight against metastatic urothelial carcinoma.
Featured Article
AVEVA and Schneider Electric spearhead digital transformation in mining
AVEVA, a global leader in industrial software driving digital transformation, has partnered with Schneider Electric to redefine what smart, sustainable mining looks like in the age of AI.
